儿科辅助剂风险评估 (PERA) 工具和应用程序,用于为儿科用剂型选择合适的辅助剂 - - 第二部分
Anjali Agrawal1, Smita Salunke2, Alfred Rumondor3
1Novo Nordisk Inc., 300 North Beacon Street, Suite 501, Watertown, MA 02472, USA.
概括
一个新的工具简化了为儿科药物选择安全的辅助剂. 儿科辅助剂风险评估 (PERA) 工具使用热图来指导辅助剂选择和风险管理.
科学领域:
- 制药科学 制药科学
- 药物开发 药物开发
- 儿科医学 儿科医学
背景情况:
- 开发安全有效的儿科药物需要严格的辅助剂风险管理.
- 儿科辅助剂风险评估 (PERA) 框架此前已引入,以指导合理的辅助剂选择.
- 本系列的第1部分详细介绍了儿童药物配方PERA框架.
研究的目的:
- 介绍儿科辅助剂风险评估 (PERA) 工具,以促进PERA框架的实际应用.
- 提供一个用户友好的方法来比较和选择儿科药品的辅助剂.
- 帮助识别信息缺口,以便在儿科药物开发中有效的基于风险的缓解计划.
主要方法:
- 开发和介绍PERA工具,这是PERA框架的一个可访问的实现.
- 使用热图评分方法 (红色,黄色,绿色类别) 进行辅助剂风险评估.
- 通过涉及新生儿口服和肠道配方的案例研究来说明该工具的实用性.
主要成果:
- 该PERA工具允许直接风险评估和辅助剂的比较.
- 它有效地突出了辅助剂数据中的潜在缺陷,这对于降低风险至关重要.
- 案例研究表明,该工具在各种辅助剂类型和施用途径中具有适用性.
结论:
- 该PERA工具简化了PERA框架的采用,用于儿童药物开发中的辅助剂风险评估.
- 它支持知情决策,以选择安全有效的辅助剂.
- 这种工具对参与儿科药物配方的制药科学家和监管机构来说是有价值的.
相关概念视频
01:28Factors Influencing Drug Absorption: Pharmaceutical Parameters
124
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
124
01:21Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
01:12Analysis of Population Pharmacokinetic Data
244
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
244
01:28Biopharmaceutics and Pharmacokinetics: Overview
1.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.9K
01:28Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K